featured
Anti-CD19 CAR T-Cell Therapy for Richter Transformation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
J. Clin. Oncol 2024 Mar 29;[EPub Ahead of Print], AS Kittai, D Bond, Y Huang, SA Bhat, E Blyth, JC Byrd, JC Chavez, MS Davids, JP Dela Cruz, MR Dowling, C Duffy, C Ho, C Jacobson, S Jaglowski, N Jain, KH Lin, C Miller, C McCarthy, Z Omer, E Parry, M Rai, KA Rogers, A Saha, L Schachter, H Scott, J Senapati, M Shadman, T Siddiqi, DM Stephens, V Vanguru, W Wierda, JA Woyach, PA ThompsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.